[
  {
    "ts": "2026-01-06T12:00:00+00:00",
    "headline": "Insulet Redefines Diabetes at CES with \"Liveable Technology\" — A New Frontier in Human-Centered Connected Health",
    "summary": "ACTON, Mass., January 06, 2026--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its debut at Consumer Electronics Show (CES) 2026, where the Company will showcase its vision for liveable technology through an immersive booth experience, expert panel session, and media demonstrations.",
    "url": "https://finance.yahoo.com/news/insulet-redefines-diabetes-ces-liveable-120000584.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e3dba1e0-b818-3309-b8ae-de95e05e7aef",
      "content": {
        "id": "e3dba1e0-b818-3309-b8ae-de95e05e7aef",
        "contentType": "STORY",
        "title": "Insulet Redefines Diabetes at CES with \"Liveable Technology\" — A New Frontier in Human-Centered Connected Health",
        "description": "",
        "summary": "ACTON, Mass., January 06, 2026--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its debut at Consumer Electronics Show (CES) 2026, where the Company will showcase its vision for liveable technology through an immersive booth experience, expert panel session, and media demonstrations.",
        "pubDate": "2026-01-06T12:00:00Z",
        "displayTime": "2026-01-06T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/6d9d972e478a828542289d72e7b1fcac",
          "originalWidth": 480,
          "originalHeight": 236,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mfEI4_lh86BGaP0eQqTzVw--~B/aD0yMzY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6d9d972e478a828542289d72e7b1fcac.cf.webp",
              "width": 480,
              "height": 236,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Opgsa10Bmq74oKPrpeTKnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6d9d972e478a828542289d72e7b1fcac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/insulet-redefines-diabetes-ces-liveable-120000584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/insulet-redefines-diabetes-ces-liveable-120000584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]